This compound is presumed to have psychoactive properties. However it's action remains untested in man.
1'-oxomyristicin-piperidine may be one of the metabolites of myristicin partially responsible for the psychedelic effects some people experience from ingesting myristicin. This metabolite has been proven to form in vivo in animals as a minor metabolite created from the ingestion of myristicin. Tests conducted on humans to detect this metabolite have not been performed. It's assumed it also occurs in humans. Because its a minor metabolite, in some people this metabolite might possibly form in quantities too low to be pharmacologically significant, which may explain why 60% of the people tested did not experience psychedelic effects from myristicin ingestion.
Instability and Decomposition
This substituted tertiary aminopropiophenone will decompose on exposure to heat, alkaline conditions, silica gel, and air with formation of the substituted allyl ketone plus the secondary amine, piperidine.
PubChem CID: This alkaloid is not presented on PubChem although research papers presented on PubChem give reference to this molecule.
Molecular Weight: 291.346 [g/mol]
Molecular Formula: C16H21NO4
Canonical SMILES: C1N(CCCC1)CCC(=O)C2=CC3=C(C(=C2)OC)OCO3